PIVONELLO, ROSARIO
 Distribuzione geografica
Continente #
NA - Nord America 18.104
AS - Asia 17.700
EU - Europa 11.136
SA - Sud America 2.266
Continente sconosciuto - Info sul continente non disponibili 658
AF - Africa 429
OC - Oceania 23
Totale 50.316
Nazione #
US - Stati Uniti d'America 17.300
SG - Singapore 7.785
RU - Federazione Russa 5.239
CN - Cina 3.459
VN - Vietnam 2.989
BR - Brasile 1.771
IT - Italia 1.716
HK - Hong Kong 1.474
DE - Germania 834
FR - Francia 611
FI - Finlandia 535
NL - Olanda 513
CA - Canada 424
SE - Svezia 388
BD - Bangladesh 386
IE - Irlanda 321
GB - Regno Unito 307
IN - India 289
UA - Ucraina 260
JP - Giappone 232
MX - Messico 186
AR - Argentina 175
KR - Corea 145
IQ - Iraq 125
TR - Turchia 108
CI - Costa d'Avorio 102
ID - Indonesia 97
EC - Ecuador 93
PL - Polonia 93
ZA - Sudafrica 88
PH - Filippine 86
ES - Italia 82
TH - Thailandia 73
CO - Colombia 64
PK - Pakistan 52
TW - Taiwan 46
KE - Kenya 45
VE - Venezuela 42
AT - Austria 40
CR - Costa Rica 37
JM - Giamaica 35
CL - Cile 33
UZ - Uzbekistan 33
EG - Egitto 32
TN - Tunisia 32
SA - Arabia Saudita 31
IL - Israele 30
JO - Giordania 30
MA - Marocco 30
MY - Malesia 30
PY - Paraguay 30
AE - Emirati Arabi Uniti 29
LT - Lituania 28
IR - Iran 25
HN - Honduras 23
BE - Belgio 22
CZ - Repubblica Ceca 20
DZ - Algeria 19
NP - Nepal 19
UY - Uruguay 19
LB - Libano 18
PE - Perù 18
BO - Bolivia 17
PT - Portogallo 17
TT - Trinidad e Tobago 16
AU - Australia 15
ET - Etiopia 14
RO - Romania 14
AZ - Azerbaigian 13
CH - Svizzera 11
NI - Nicaragua 11
GT - Guatemala 10
OM - Oman 10
PA - Panama 10
SY - Repubblica araba siriana 10
DO - Repubblica Dominicana 9
BB - Barbados 8
KZ - Kazakistan 8
LV - Lettonia 8
PS - Palestinian Territory 8
AM - Armenia 7
GR - Grecia 7
NG - Nigeria 7
PR - Porto Rico 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
BG - Bulgaria 6
BS - Bahamas 6
HU - Ungheria 6
KG - Kirghizistan 6
KW - Kuwait 6
SN - Senegal 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
MD - Moldavia 5
RS - Serbia 5
SI - Slovenia 5
SV - El Salvador 5
Totale 49.523
Città #
Singapore 3.729
San Jose 3.266
Hong Kong 1.438
Moscow 1.274
Ashburn 1.219
Chandler 1.124
Ho Chi Minh City 894
Beijing 863
Hanoi 627
Santa Clara 618
Hefei 611
Millbury 473
Los Angeles 444
The Dalles 432
Amsterdam 426
Council Bluffs 426
Naples 420
Lauterbourg 391
Princeton 305
Munich 283
Jacksonville 278
New York 272
Nanjing 259
Buffalo 233
Dallas 200
Wilmington 200
Tokyo 198
Boston 173
São Paulo 172
Phoenix 151
Redondo Beach 149
Napoli 138
Da Nang 131
Des Moines 126
Ottawa 122
Orem 121
Helsinki 120
Turku 116
Houston 108
Haiphong 106
Seoul 106
Montreal 99
Chicago 98
Frankfurt am Main 97
Atlanta 96
San Francisco 92
Rome 89
Seattle 86
Woodbridge 85
Boardman 79
Lawrence 79
Nanchang 78
Mexico City 75
Warsaw 75
Denver 73
Milan 71
Toronto 67
Brooklyn 64
Falkenstein 61
Hebei 58
Rio de Janeiro 55
Chennai 54
London 53
Nuremberg 52
Tianjin 51
Biên Hòa 48
Johannesburg 46
Stockholm 45
Hải Dương 43
Manchester 43
Shenyang 43
Baghdad 42
Nairobi 42
Poplar 42
Changsha 39
Ann Arbor 37
Norwalk 36
Can Tho 35
Curitiba 35
Shanghai 34
Brasília 33
Columbus 33
Jiaxing 33
Memphis 33
Ankara 32
Belo Horizonte 31
Kochi 31
Kronberg 31
Quito 31
Tashkent 30
Dhaka 29
New Delhi 29
Porto Alegre 29
San Mateo 29
Falls Church 28
Ninh Bình 28
Mumbai 27
Dublin 26
Guayaquil 26
Guangzhou 25
Totale 25.733
Nome #
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 690
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 544
Effects of Chrono-Exercise and Chrono-Nutrition on Muscle Health: Understanding the Molecular Mechanisms Activated by Timed Exercise and Consumption of Proteins and Carbohydrates 256
Does an increase in adipose tissue ‘weight’ affect male fertility? A systematic review and meta-analysis based on semen analysis performed using the WHO 2010 criteria 240
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas 240
Medical consequences of acromegaly: what are the effects of biochemical control? 225
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 223
Spot-light on microbiota in obesity and cancer 216
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy. 207
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 206
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 202
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 202
Growth hormone, prolactin, and sexuality. 200
Exposure to artificial light at night: A common link for obesity and cancer? 198
Effect of antioxidants on semen parameters in men with oligo-astheno-teratozoospermia: a network meta-analysis 196
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 185
The role of vitamin D in male fertility: A focus on the testis 185
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology 185
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 184
Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. 183
1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation 179
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease 179
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 178
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 177
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 176
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study 175
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 170
Flavor perception test: evaluation in patients with Kallmann syndrome 166
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 165
Bisphenol A: An emerging threat to female fertility 165
Severe systemic complications of acromegaly 164
Association between vitamin D and sperm parameters: Clinical evidence 164
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 164
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 163
Cardiovascular consequences of early-onset growth hormone excess 163
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 163
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 162
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 161
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 160
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 160
Neuropsychiatric disorders in Cushing's syndrome. 159
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 159
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 158
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 157
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 157
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 157
Hypertension in acromegaly and in the normal population: prevalence and determinants 155
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 155
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 155
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 155
Air pollution and female fertility: A systematic review of literature 155
Cabergoline counteracts adipose and skeletal muscle lipid accumulation: A novel therapeutic approach to obesity? 154
The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review 154
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 153
Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission 150
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 150
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study 150
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 150
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 150
Investigational drugs for the treatment of acromegaly: new agents to transform therapy 149
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 149
Acromegaly and the cardiovascular system 149
The effect of FT500 Plus® on ovarian stimulation in PCOS women 149
Pathophysiology of diabetes mellitus in Cushing's syndrome. 148
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 147
Acromegalic axial arthropathy: a clinical case-control study 147
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 147
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 146
Cardiac effect of thyrotoxicosis in acromegaly 146
Shedding new light on female fertility: The role of vitamin D 146
Approach to the Patient with Prolactinoma 145
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 145
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 145
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 144
New perspectives in the medical treatment of acromegaly 144
Cushing's syndrome: aftermath of the cure. 144
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 144
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 143
Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly 143
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 143
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 143
The Treatment of Cushing's Disease. 142
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 141
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 141
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 140
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 140
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 140
Adverse events associated with somatostatin analogs in acromegaly. 139
Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. 139
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 139
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 139
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life 139
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 138
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas 138
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 138
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 138
Effect of Cabergoline on Metabolism in Prolactinomas. 138
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 138
Metabolic alterations and cardiovascular outcomes of cortisol excess 137
Evaluation of morphometric parameters and chromatin integrity in the sperm of stallion food supplemented with Maca. 137
Totale 17.101
Categoria #
all - tutte 166.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.170 0 0 10 25 54 215 29 61 372 120 376 908
2022/20232.709 409 227 75 213 329 262 27 230 374 414 112 37
2023/20241.766 86 271 239 142 80 115 49 190 26 36 313 219
2024/202511.809 632 758 99 95 252 584 1.326 761 859 1.053 4.298 1.092
2025/202624.433 2.578 1.855 2.431 2.103 4.015 917 2.936 1.403 3.107 1.399 736 953
2026/20274.012 1.771 1.439 802 0 0 0 0 0 0 0 0 0
Totale 50.316